Literature DB >> 11925926

[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].

R Konno1.   

Abstract

Gene expression of human ovarian carcinoma cell lines and epithelial ovarian tumors was examined by oligonucleotide microarray for about 6000 human cDNAs. (1) Comparison of gene expression between CDDP-sensitive human ovarian serous adenocarcinoma cell lines and CDDP-resistant cell lines revealed that gamma-glutamylcysteine synthetase, glutathione peroxidase-like protein, dehydrogenase (UGDH), NAD(P)H: quinoneoxireductase, glucose-6-phosphatase, ornithine decarboxylase and dihydrodiol dehydrogenase were associated with a mechanism of CDDP-resistance. Comparison of gene expression between taxol-sensitive human ovarian cell lines and taxol-resistant cell lines showed that up-regulation of 30 kinds of gene expression including MDR and semaphorin E in taxol-resistant cell lines. (2) Comparison of gene expression among serous adenocarcinomas, clear cell adenocarcinomas and non-cancerous ovarian tissues by hierarchical clustering demonstrated that clear difference between carcinomas and non-cancerous ovarian tissues but not obvious difference between serous and clear adenocarcinomas. Genes that were up- and down-regulated specifically in these two types of ovarian carcinomas were further selected by the criteria that difference in the mRNA level by more than 4-fold between tumors and non-cancerous tissues. Tissue type specific alterations of gene expression are likely to play important roles in the carcinogenesis of epithelial ovarian tumors. cDNA microarray is a powerful and high-throughput tool to analyze gene expression of cancer development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11925926

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  3 in total

Review 1.  Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer.

Authors:  Abhilasha Purohit; Anguraj Sadanandam; Pavan Myneni; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2014-09-28

2.  The evaluative value of Sema3C and MFN2 co-expression detected by immunohistochemistry for prognosis in hepatocellular carcinoma patients after hepatectomy.

Authors:  Xu Feng; Kelei Zhu; Jinghua Liu; Jiang Chen; Jiacheng Tang; Yuelong Liang; Renan Jin; Xiao Liang; Xiujun Cai
Journal:  Onco Targets Ther       Date:  2016-05-30       Impact factor: 4.147

3.  SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

Authors:  James W Peacock; Ario Takeuchi; Norihiro Hayashi; Liangliang Liu; Kevin J Tam; Nader Al Nakouzi; Nastaran Khazamipour; Tabitha Tombe; Takashi Dejima; Kevin Ck Lee; Masaki Shiota; Daksh Thaper; Wilson Cw Lee; Daniel Hf Hui; Hidetoshi Kuruma; Larissa Ivanova; Parvin Yenki; Ivy Zf Jiao; Shahram Khosravi; Alice L-F Mui; Ladan Fazli; Amina Zoubeidi; Mads Daugaard; Martin E Gleave; Christopher J Ong
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.